M1 muscarinic cholinergic receptor agonist

M1 muscarinic cholinergic receptor agonist has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Nov 7, 2026: “Drug appeared to aid memory updating in middle-aged male mice”.

Intervention

1 paper studies it1 findingUpdated Nov 7, 2026

1 new paper in 30 daysSee all 1 papers on M1 muscarinic cholinergic receptor agonist

At a glance

The findings reach mice, none yet in people. 1 lab.

1 lab

Animals1

What did studies of M1 muscarinic cholinergic receptor agonist find?

Studies of M1 muscarinic cholinergic receptor agonist measured 1 outcome; the most studied are memory updating (1 study).

Memory updating

upin mice1

1 study

M1 muscarinic cholinergic receptor agonist improves memory updating in mice (pre-reactivation administration).
“pre-reactivation administration of an M1 muscarinic cholinergic receptor agonist appeared to promote memory destabilization in middle-aged mice, enabling memory updating.”
Animalspre-reactivation administrationmales
Drug appeared to aid memory updating in middle-aged male mice
Scientific reportsNov 7, 2026

Latest

1 paper in 12 months

Scientific ReportsNov 7

Drug appeared to aid memory updating in middle-aged male mice

In experiments, male mice aged 10–15 months learned and retained object locations, but reminders did not readily make those memories open to change.In experiments, male mice aged 10–15 months learned and retained object locations, but reminders did not readily make those memories open to change.

Mouse studyInterventions

Paper